Afficher la couverture 'The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value | Cohen, Pascale, A' en grand format
/5

0 avis

The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value

Archive ouverte

Cohen, Pascale, A | Donini, Caterina, F | Nguyen, Nhan, T | Lincet, Hubert, F | Vendrell, Julie, A

Edité par CCSD ; Impact journals -

International audience. The recently described oncogene ZNF217 belongs to a chromosomal region that is frequently amplified in human cancers. Recent findings have revealed that alternative mechanisms such as epigenetic regulation also govern the expression of the encoded ZNF217 protein. Newly discovered molecular functions of ZNF217 indicate that it orchestrates complex intracellular circuits as a new key regulator of tumorigenesis. In this review, we focus on recent research on ZNF217-driven molecular functions in human cancers, revisiting major hallmarks of cancer and highlighting the downstream molecular targets and signaling pathways of ZNF217. We also discuss the exciting translational medicine investigating ZNF217 expression levels as a new powerful biomarker, and ZNF217 as a candidate target for future anti-cancer therapies.

Suggestions

Du même auteur

Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer

Archive ouverte | Vendrell, Julie, A | CCSD

International audience. ZNF217 is a candidate oncogene with a wide variety of deleterious functions in breast cancer. Here, we aimed at investigating in a pilot prospective study the association between ZNF217 mRNA ...

mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene‐expression levels

Archive ouverte | Ghayad, Sandra, E | CCSD

International audience. Activation of the Akt/mammalian target of rapamycin (mTOR) pathway has been shown to be associated with resistance to endocrine therapy in estrogen receptor alpha (ERa)-positive breast cancer...

Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay

Archive ouverte | Donini, Caterina, F | CCSD

International audience. It is of utmost importance to decipher the role of chronic exposure to low doses of environmental carcinogens on breast cancer progression. The early-transformed triple-negative human mammary...

Chargement des enrichissements...